Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Inc. Recognized by Massachusetts House of Representatives as Manufacturer of the Year for District
September 29, 2021 09:19 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm
September 22, 2021 07:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and ULM, Germany, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scientific focus
September 20, 2021 07:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET | Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET | Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
February 11, 2021 04:10 ET | Rentschler Biopharma SE
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility
May 27, 2020 09:00 ET | Rentschler Biopharma SE
Innovative agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in developmentRentschler Biopharma’s U.S. site expansion progressing on track...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Appoints New Executives to Join U.S. Team
November 18, 2019 10:00 ET | Rentschler Biopharma SE
New heads of Process Sciences and Human Resources departmentsBoth positions newly created as site expands and ramps up business  LAUPHEIM, Germany and MILFORD, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE)...